Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Download PDF
June 15, 2016
/
News
Share
the Post
Related
Posts
Stage set for access to Hepatitis C treatment in Malaysia
Four Indian generic companies take sub license from MPP on daclatasvir
Part 1: What is hepatitis C and how is it diagnosed?
Asia Pacific Situational Updates on Generic DAAs – June 2017
BMS’ patent bid for Hep C treatment Daclatasvir Challenged
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
APN+ joins MTAAG in congratulating Malaysia on sofosbuvir compulsory license
